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The 2003 Annual Scientific Sessions of the American
Society of Echocardiography (ASE) survived a last-minute
change in venue from Toronto to Las Vegas, attracting
more than 2,400 registrants to a multidimensional program.
This paper outlines the structure of the meeting and
highlights presentations related to clinical and research
applications of echocardiography. It is worth noting that the
ASE provides disease-based as well as technique-based
education, a concept that is reflected in both the subject
matter presented and the faculty of the Annual Scientific
Sessions.
The membership of the ASE is diverse and includes
physicians (cardiologists, radiologists, anesthesiologists, and
fellows) as well as sonographers, nurses, and department
managers. To meet the continuing educational needs of
members, the ASE 2003 included the following tracks:
Disease of the Day (coronary artery disease, valve disease,
and heart failure on successive days); Meet the Experts/
How to; Cutting-Edge Technology; Cases; Core Curricu-
lum (ultrasound basics); Sonography; Intraoperative Echo-
cardiography and Pediatric Echocardiography. Special
sessions included technique-based symposia and co-
sponsored sessions with the Society for Vascular Ultra-
sound, European Society of Cardiology, Intersocietal Com-
mission for the Accreditation of Echocardiography
Laboratories, and the ASE Women’s Health Advisory
Group. A session was also offered in Spanish. Special
lectures included: the Edler Lecture, “Good Morning
ASE,” given by President Pam Douglas; the Feigenbaum
Lecture, “Should We Examine the Heart or the Myocar-
dium: Recent Advances in Tissue Characterization,” by Dr.
Thomas Marwick; and “Back to the Future,” a review of the
evolution of echocardiography, by Dr. Jamil Tajik. Infor-
mal, small-group, how-to sessions and two popular “games”
offered a change in tempo from structured didactic sessions.
“Echo Jeopardy,” the creation of John Gorcsan III, featured
echocardiography luminaries who competed using the
game-show format. A local society challenge had a “stump
the other team” approach. The President’s Reception this
year featured a celebration of the 50th anniversary of
echocardiography.
Major topics for the didactic and abstract sessions in-
cluded abnormalities of ventricular function, valve disease
with a focus on the intraoperative setting, contrast
echocardiography, new technology, and pediatric echo-
cardiography.
VENTRICULAR FUNCTION
The ASE 2003 showcased new methods for assessing
ventricular systolic and diastolic function, many of which
hold the promise of noninvasive indexes that are load- and
translation-independent. These included methods based on
Doppler tissue imaging (strain and strain rate), three-
dimensional (real-time and reconstructive) techniques, and
tissue tracking. These modalities enhance the quantitation
and reproducibility of cardiac ultrasound, and application of
these and other techniques for assessing patients who are
candidates for biventricular pacing and mechanical assist to
the failing ventricle shows enormous promise. These quan-
titative techniques and ultrasound contrast methods are
increasingly being applied to increase the accuracy of state-
of-the-art stress echocardiography. In addition, the invited
speakers, Drs. Gary Heller, Warren Manning, and Joao
Lima, compared these techniques with the latest advances in
complementary nuclear and magnetic resonance technolo-
gies.
The Feigenbaum Lectureship is awarded annually to an
outstanding young investigator. This year’s recipient,
Thomas Marwick, who has previously made major contri-
butions to the field of stress echocardiography, focused on
advances in tissue Doppler, strain rate, and strain imaging.
Tissue Doppler recordings represent the velocity of move-
ment of the myocardium itself during contraction and
filling. Dr. Marwick discussed the superiority of these
techniques over conventional gray-scale imaging to demon-
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strate early myocardial functional abnormalities in patients
with subtle forms of dysfunction, in particular, diabetic
cardiomyopathy. Strain and strain rate calculations are
derived from the transmyocardial velocity gradients delin-
eated by tissue Doppler, are independent of overall cardiac
motion and tethering, and appear to provide the earliest and
most sensitive measures to detect impaired myocardial
performance.
Michael Firstenberg, MD, was featured as one of the
Young Investigator Award finalists. The work done by him
and his colleagues demonstrated a relationship between
ventricular contractility and early diastolic intraventricular
pressure gradients derived from color M-mode recordings,
which may serve as a link between systolic contractility and
early diastolic function (1).
The disease-based discussions incorporated a multimo-
dality discussion of dilated and hypertrophic cardiomyopa-
thy, hypertensive heart disease, heart failure with normal
systolic function, and more unusual myopathies with dis-
tinct echocardiographic features. Douglas Wigle, MD, an
expert in hypertrophic myopathy, presented historic and
recent data on this disease and emphasized the major role
that echocardiography plays in the clinical care of affected
patients.
The topics of heart failure and ventricular function were
featured as one of the “Disease of the Day” topics. Dr.
Steven Lester reviewed the assessment of systolic function
using conventional two-dimensional and newer Doppler
tissue-based approaches. Dr. Allan Klein reviewed the
state-of-the-art assessment of left ventricular (LV) diastolic
function by combining Doppler measures of mitral and
pulmonary venous flow, mitral annular velocities assessed by
Doppler tissue imaging, and color Doppler M-mode–
derived mitral inflow propagation. He pointed out that a
constellation of findings may be recognized by echocardi-
ography in the presence of diastolic dysfunction, which
represents positive evidence of its existence, pathophysio-
logic type, and severity. Dr. Mario Garcia reviewed the
important role of echocardiography in surgical therapy for
the failing heart, including the Dor procedure for ventricular
volume reduction in patients with apical aneurysms, and
various cardiac containment devices that are evolving to
attenuate the deleterious process of ventricular remodeling.
An important recent therapeutic advance for heart failure
associated with left bundle branch block is biventricular
pacing, also known as cardiac resynchronization therapy. In
their lectures, Drs. Picard, Thomas, Gorcsan, and Nihoy-
annopoulos reviewed recent advances in echocardiographic
Doppler techniques to quantify mechanical dyssynchrony in
these patients. Such measurements are critical to select
patients who will benefit from resynchronization therapy.
Dr. Sogaard and his co-workers presented a new technique
known as tissue synchronization imaging. This is a modi-
fication of the tissue Doppler method in which the myo-
cardium is color coded for measurements of time-to-peak
velocity, thus providing a quantitative means of assessing
LV synchrony. It superimposes temporal information on
regional cardiac anatomy.
Recent research in ventricular function was highlighted in
the presentation of Young Investigator Award finalist, Dr.
Troughton, who reported echocardiographic determinants
of brain natriuretic peptide levels in symptomatic systolic
heart failure (2). Kanzaki et al. (3) demonstrated consistent
and significant early reductions in mitral regurgitation
occurring with biventricular pacing, using the volumetric
Doppler method. Pislaru et al. (4) reported on the use of
cardiac elastography to detect differences in myocardial
compliance of stunned and infarcted reperfused myocar-
dium. Gao et al. (5) presented work on assessing ventricular
function with tissue Doppler acceleration, the first deriva-
tive of velocity. In addition, Reynolds et al. (6) provided new
insights into the causes of paradoxical septal motion in a
large series of patients undergoing cardiac surgery. This is
only a small sample of the many evolving roles of echocar-
diography for the assessment of cardiac function that were
presented at these scientific sessions.
VALVULAR FUNCTION
A team approach. Management of valvular heart disease
requires a clear understanding of disease etiology, quantita-
tion of its severity, and determination of the optimal timing
and choice of surgical intervention. Improvements in the
anatomic and functional assessment of valve disease by
echocardiography and innovations in surgical techniques
have led to earlier surgical intervention and better long-term
patient outcomes. The intraoperative session track high-
lighted the important collaborative relationship that has
developed between cardiac surgeons, cardiologists, and an-
esthesiologists performing perioperative echocardiography.
Cardiac surgeons have increasingly recognized the impor-
tance of echocardiography for clinical decision-making and
patient follow-up. Echocardiographers have learned how to
provide key information to the surgeon and to understand
how surgical decisions are made. The faculty included three
highly regarded cardiac surgeons: Drs. Larry Cohn, Tirone
David, and John Elefteriades. Sessions were disease-based
and focused on clinical decision-making and outcomes.
Aortic valve disease. In patients with valvular heart dis-
ease, echocardiography is essential for determining disease
etiology and severity. In patients with aortic valve disease,
the most common causes of disease are degeneration, a
bicuspid aortic valve, endocarditis, and functional regurgi-
tation secondary to aortic root disease. Aortic valve repair is
possible in only a small percentage of patients, primarily
those with non-stenosed bicuspid aortic valves or cusp
prolapse. When valve replacement is required, controversy
still exists surrounding the best valve choice. Newer tissue
prostheses appear to have better longevity. The decision
about which valve to implant is made based on patient age,
need for anticoagulation or re-operation, and patient life-
style choices. The Ross procedure is an effective long-term
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solution for younger patients requiring aortic valve replace-
ment but requires careful avoidance of geometric mismatch
for optimal results. The majority of patients undergoing this
procedure have bicuspid aortic valves. This condition is
associated with annulo-aortic ectasia and aortic root dila-
tion, which are the leading causes of late autograft failure.
The Ross Registry indicates that surgeons highly experi-
enced in performing this procedure can achieve excellent
results; however, the results are not uniformly successful.
Echocardiographic studies are essential for follow-up. At
the Toronto General Hospital, survival is 98% at seven
years, with 86% freedom from 3 or 4 aortic regurgita-
tion and 95% freedom from re-operation on the pulmonary
autograft.
Aortic aneurysm. Dr. Elefteriades presented data from
Yale detailing the natural history of thoracic aortic aneu-
rysms and an algorithm for making a decision about the
timing of aortic root replacement surgery. A prospectively
accumulated database of over 1,600 patients with thoracic
aneurysms and dissection has been accumulated. Thoracic
aortic aneurysms grow at an annual rate of 0.1 cm/year,
although there is individual variability. When an ascending
thoracic aneurysm reaches 6 cm, adverse annual event rates
reach 3.6% for rupture, 3.7% for dissection, and 10.8% for
death. Surgical mortality for thoracic aneurysms was only
2.5%, confirming that surgery can be undertaken at a
relatively low risk. Risk benefit analysis strongly supports
elective ascending aortic root replacement when the ascend-
ing aorta reaches 5.5 cm and 5.0 cm if the patient has
Marfan syndrome. Intraoperative echocardiography is es-
sential in these patients and can predict the need for
supracoronary versus infracoronary root replacement. Aortic
valve sparing surgery (David operation) with re-implantation
of the valve in a Dacron graft is frequently possible in
patients with aortic root aneurysms. This operation is
associated with good results at 10-year follow-up with 75%
freedom from moderate or worse aortic regurgitation.
Mitral valve repair. Mitral valve repair for degenerative
disease is being increasingly performed and has been shown
to decrease late mortality and morbidity. In three Mayo
clinic studies, symptomatic patients with flail leaflets offered
early mitral repair were shown to have better late outcomes
than patients treated medically. Dr. David presented a study
of 488 consecutive patients undergoing mitral valve repair
for floppy valves, 199 of whom were asymptomatic or
minimally symptomatic. Asymptomatic patients were
younger and had better ventricular function, a lower inci-
dence of coronary disease, and higher rates of atrial fibril-
lation than symptomatic patients. Survival at 15 years for
asymptomatic patients was 76%, which was identical to a
general Canadian population matched for age and gender.
Freedom from re-operation at 15 years was 91%, demon-
strating the long-term effectiveness of mitral valve repair
when performed by an expert surgeon. This lends further
weight to the performance of early mitral valve repair for
severe mitral regurgitation, as long as there is a high
likelihood that repair rather than valve replacement is
possible.
The ability to repair more floppy valves has been made
possible by important surgical advances, including the use of
artificial chordae, annular reconstruction, and minimally
invasive thoracotomy. Surgical repair is rendered increas-
ingly more difficult in the setting of involvement of the
anterior leaflet, severe myxomatous degeneration, and an-
nular abnormalities such as dysjunction or severe calcifica-
tion. Transesophageal echocardiographic (TEE) studies can
accurately quantitate the degree of leaflet and annular
disease. Data from Dr. Omran, comparing intraoperative
TEE and surgical pathology, show an excellent correlation
with the central portions of both leaflets most commonly
involved (P2, A2), followed by medial segments (P3, A3)
and infrequently lateral segments (P1, A1). This informa-
tion predicts the extent of surgery required and, therefore,
the likelihood of repair, which will vary with the surgeon’s
capabilities. As demonstrated by Dr. Savage from the
Cleveland Clinic, intraoperative TEE studies are essential
in all patients undergoing mitral repair to recognize com-
plications such as dynamic outflow obstruction, inadequate
repair, inadvertent coronary ligation, and mitral inflow
obstruction.
Ischemic mitral regurgitation is more difficult to repair
due to multiple potential abnormalities involving the mitral
annulus, papillary muscles, chordae, and distorted LV ge-
ometry. The use of mitral annular rings alone does not deal
with abnormalities of abnormal LV geometry and often may
not adequately improve regurgitation. Innovations in three-
dimensional echocardiography show great promise in better
understanding the mechanism of regurgitation and the
importance of leaflet tethering. Experimental surgical ap-
proaches proposed by Dr. Robert Levine include the use of
an external inflatable patch device in animal models to
improve geometric distortion of the LV and the cutting of
leaflet-tethering commissural chordae. Dr. David has used
the latter technique in a small number of patients with good
early results.
Hypertrophic cardiomyopathy. Myectomy in patients
with hypertrophic obstructive cardiomyopathy refractory to
medical therapy can be performed with low mortality and
morbidity, with excellent long-term results. Echocardiogra-
phy can provide essential information on the length and
extent of myectomy required so that septal muscle is
removed about 1 cm below the level of leaflet septal contact.
Associated mitral regurgitation is usually greatly improved
or abolished, unless independent factors are present. About
25% of patients require additional surgery to relieve obstruc-
tion at other levels, to bypass or unroof coronary arteries, or
for valve repair or replacement. Intraoperative complica-
tions, such as incomplete relief of obstruction or creation of
a ventricular septal defect, can be detected and corrected
during a second pump run.
Videoscopic and small-incision surgery have been used
with great success in noncardiac operations. As shown by
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Dr. Cohn, minimally invasive cardiac surgery is increasingly
being performed with an operative mortality similar to
open-sternotomy cases. Benefits include a shorter length of
hospital stay, decreased need for blood transfusion, less
atrial fibrillation, faster patient rehabilitation, and lower
hospital cost. Transesophageal echocardiography is often
essential to monitor operation quality and air removal.
Intraoperative echocardiography. A session entitled “Pa-
tient Outcomes and Intraoperative Echocardiography:
What Do We Know?,” presented by a group of cardiac
anesthesiologists, included presentations and discussion by
Drs. Mathew, Swaminathan, Shernan, and Vezina. The
session emphasized the important areas in which intraop-
erative TEE has helped guide intraoperative decision-
making in patients with valvular and coronary disease.
Controlled outcomes studies are needed to prove the benefit
and delineate the role of intraoperative TEE, especially as
its use becomes more routine. Perioperative neurologic
dysfunction remains an important complication in patients
with atherosclerotic heart disease. Epi-aortic echocardio-
graphic studies can identify patients at high risk of embolic
complications. Dr. Kathryn Glas presented a study indicat-
ing that this risk can be reduced by the use of alternate
cannulation sites and off-pump techniques with a “no-
touch” approach to the atherosclerotic aorta.
In the past decade, major advances have been made in the
management of valvular heart disease. Echocardiography
has played an important role initially in the determination of
disease etiology and severity. More recently, intraoperative
echocardiographic studies have become the standard of care,
especially in patients undergoing valve repair or innovative
surgery. Studies are becoming a routine adjunct to the
surgical procedure, with greater reliance on performance of
perioperative echocardiography by cardiac anesthesiologists.
The ongoing collaboration of surgeons and echocardi-
ographers, along with improvements in technology and
surgical innovation, should lead to even better patient
outcomes in the future.
CONTRAST ECHOCARDIOGRAPHY
Contrast echocardiography remains an active and growing
field of interest in echocardiography. Despite the fact that
there is no contrast agent that has been approved for
myocardial contrast echocardiography (MCE) (or perfusion
imaging), expertise in this modality is progressively increas-
ing. In some laboratories, methods of MCE for assessing
perfusion at rest and with exercise have moved into the
clinical mainstream. Successful performance of contrast
echocardiography requires knowledge regarding the han-
dling and administration of the agents and optimal instru-
ment settings, and discussions were devoted to the “how to”
of implementation and the complementary roles played by
physicians, sonographers, and nurses. Abstract presentations
built on previous validation of MCE, using nuclear, mag-
netic resonance, and angiographic gold standards to explore
the use of contrast echocardiographic-determined perfusion
to define prognosis in patients with coronary artery disease.
Insights into coronary physiology in health and disease
provided by contrast echocardiography, as well as the impact
of ultrasound on microbubbles, were also reviewed.
MCE for coronary pathophysiology. The value of MCE
for assessing microvascular function and perfusion patterns
was shown in several studies. One study showed the
differences in perfusion patterns obtained during distal
embolization of various size microbubbles. Another showed
how direct intracoronary administration of dobutamine and
adenosine caused similar increases in myocardial blood flow
velocity in normal myocardium and decreases in myocardial
blood volume in the presence of coronary stenosis. Thus, the
direct coronary effects of adenosine and dobutamine differ
from their intravenous effects. Also examined was the effect
of the K channel opener, nicorandil, in a model of
coronary occlusion. This agent increased blood flow in the
risk area, despite causing hypotension at large doses. An-
other study showed that brain natriuretic peptide limits
infarct size in a model of coronary occlusion, whereas
another showed that patients with amyloidosis have im-
paired function of coronary arterioles, despite having normal
epicardial coronary arteries. A separate study confirmed that
the cyclic changes in backscatter seen on MCE are due to
changes in myocardial arteriolar blood volume, corroborat-
ing previous observations.
MCE in acute coronary syndromes. One study showed
that MCE had incremental value over other parameters
measured in these patients, whereas another involving800
patients showed that the timing of MCE after the onset of
chest pain (up to 12 h) did not affect the ability of MCE to
prognosticate events up to 14 days later. A study of 82
consecutive patients with acute anterior wall infarction
showed that in those with dyssynergy, the perfusion score
index on MCE predicted LV function on follow-up and was
a better marker for this purpose than other routinely
derived clinical markers, thus confirming previous obser-
vations. Dr. Janardhanian, a finalist for the Young
Investigator Award competition, confirmed the ability of
MCE to quantify the transmural extent of necrosis in
patients with acute myocardial infarction (7). Although
this has been previously shown in animal studies, the new
finding here was the excellent correlation of MCE with
magnetic resonance imaging (MRI), a newer method of
assessing perfusion.
Low-energy, real-time MCE. Although real-time, low
mechanical index imaging is popular because of the ease of
microbubble agent administration and the ability to simul-
taneously see wall motion, the limitations of this approach
are becoming apparent. One presentation that generated
considerable interest examined the effect of ultrasound on
microbubble destruction during low-power, real-time im-
aging. It was shown that if the number of pulses required to
destroy bubbles to derive replenishment curves was 6,
there was an artificial reduction in the measured micro-
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bubble velocity. Furthermore, even very low mechanical
indexes resulted in a gradual destruction of microbubbles
during their microvascular transit and a progressive increase
in the measured microbubble velocity. The type of multi-
pulse technique and the polarity of pulses used during
low-power imaging also influenced the rate of microbubble
destruction. Because of the low dynamic range compared
with ultraharmonic B-mode imaging, these methods were
also reported to underestimate the extent of myocardial
viability in patients with poor LV function.
MCE for coronary flow reserve. The MCE measurements
of flow reserve were reported in several different patient
populations (e.g., hypertension, diabetes, and myocardial
infarction) by different investigators. Because capillaries are
the bottleneck for hyperemic flow after the exogenous
administration of vasodilators, measuring microbubble ve-
locity in tissue rather than coronary flow velocity in larger
vessels makes more sense. Drinking of black and green tea
was shown to improve flow reserve. Flow reserve was shown
to be maximized in patients with diabetes whose blood
sugar was well controlled. The mechanism behind the
improvement in flow reserve by euglycemia in diabetics and
by drinking green and black tea in normal subjects was not
explored.
New insights into coronary physiology and pathophysi-
ology with MCE dominated the lectures and state-of-the-
art presentations. Use of echocardiography in assessing
flow-function relationships can be a very powerful tool in
patients with coronary artery disease. In this regard, the
importance of quantification of both flow (with MCE) and
function (particularly with contrast-enhanced LV opacifi-
cation) was stressed in order to be able to separate ischemia,
infarction, stunning, and hibernation. Several abstracts also
dealt with this issue. Newer imaging methods, such as 1.5
harmonic imaging, with and without real-time digital sub-
traction, received a lot of attention. The MCE image
quality with these new methods is excellent and, similar to
ultraharmonic imaging, they have great promise for assess-
ing myocardial perfusion with intermittent high mechanical
index imaging.
Automation of MCE. The need for automation for quan-
tification, display, and interpretation of MCE images was
also stressed by several computer-savvy investigators. In
particular, different algorithms for image alignment and
segmentation were presented. Also discussed were the
merits and limitations of parametric imaging. It is becoming
increasingly clear that quantitative tools will make the
routine acceptance of MCE more feasible.
Targeted diagnostics and therapy. Interest in targeted
microbubble techniques for imaging and therapeutic appli-
cations remains high. Techniques for gene and drug deliv-
ery, imaging angiogenesis and inflammation, as well as
contrast-enhanced thrombolysis, were reviewed. This year’s
Young Investigator Award went to Dr. Bekeredjian, who
reported gene delivery to tissue via ultrasound-induced
microbubble destruction (8).
MCE for cardiac masses. An interesting and relatively
new indication for MCE described at the meeting was the
discrimination of intracardiac masses based on quantitative
MCE. Compared with myocardium, tumors showed higher
blood velocity and volume, which also separated them from
intracardiac thrombi. Several different types of cardiac
tumors were discussed. Another interesting new application
was the use of contrast media for the diagnosis of acute
aortic dissection. In patients with obstructive hypertrophic
cardiomyopathy, MCE has been increasingly used to guide
ethanol ablation. Although the numbers were small, a study
reported that the size of the risk area on MCE predicts
post-procedural complications in this setting.
Overall, the echocardiographic community is becoming
more familiar with contrast echocardiography, particularly
MCE and its potential for assessing the microvasculature.
The variety of topics addressed indicates that there is both
intellectual and pragmatic interest in this modality. It is
likely that the field will grow even more rapidly when an
agent has been approved for myocardial perfusion and when
a reimbursement schedule is put in place. The adoption of
this technique for assessing resting and stress myocardial
perfusion will have obvious implications in the care of
patients with coronary artery disease.
NEW TECHNOLOGY
In addition to technical advances in the assessment of
ventricular function and contrast perfusion noted earlier, the
ASE 2003 highlighted the emerging roles and clinical
applications of intracardiac, real-time and reconstructive
three-dimensional, and hand-carried ultrasound. Current
intracardiac ultrasound catheters—steerable devices with
imaging and Doppler capability—are gaining widespread
use in guiding catheter-based interventions, including ar-
rhythmia ablation, valvuloplasty, and device closure. Real-
time, three-dimensional techniques with new color flow
mapping capability are particularly useful in displaying
valvular and ventricular anatomy and physiology. Hand-
carried devices with varying capabilities are being used as an
adjunct to physical examination in a variety of settings,
including the emergency room, intensive care unit, and
medical student teaching.
PEDIATRIC ECHOCARDIOGRAPHY
The Council on Pediatric Echocardiography honored David
J. Sahn, MD, with its Founders Award for his remarkable
contributions to the field of congenital cardiac imaging. Dr.
Sahn has been at the forefront of cardiac ultrasound
throughout its evolution, making key contributions for over
25 years.
The Pediatric Track of the Scientific Sessions highlighted
recent innovations in pediatric cardiac imaging. Dr. Pedro
del Nido from the Children’s Hospital in Boston discussed
his collaborative work with Dr. Gerald Marx on real-time,
three-dimensional echocardiographic guidance of robotic
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surgery for intracardiac repair of congenital cardiac anom-
alies. Although current techniques of thoracoscopic surgery
on extracardiac structures are based on optical imaging
(video-assisted), a different imaging strategy is required for
intracardiac surgery on the beating heart (off cardiopulmo-
nary bypass). Dr. del Nido discussed his team’s work on
refining image-rendering algorithms and instrumentation to
achieve three-dimensional ultrasound images that appear
similar to those obtained using an endoscope. Their efforts
are currently directed at developing image-processing tech-
niques to enhance the ultrasound images, modifying surgical
instruments that are more clearly visualized by three-
dimensional echocardiography, and refining techniques to
perform surgical manipulations under ultrasound guidance.
The investigators found, for example, that coating the
robot’s arms with a thin layer of rubber significantly reduced
specular reflection from the instrument, resulting in de-
creased image artifacts and enhanced depiction of the
robot’s arms. In addition to real-time, three-dimensional
echocardiography, Dr. del Nido’s group is also exploring the
use of electromagnetic instrument tracking, in collaboration
with Dr. John Triedman from the Children’s Hospital in
Boston, as well as with investigators from Boston University
(image processing), Harvard University (bioengineering),
and industry.
High-intensity focused ultrasound (HIFU). Dr. Achi
Ludomirsky from the University of Michigan reviewed the
potential applications of HIFU in patients with congenital
heart disease (CHD). In contrast to the nonharmful high-
frequency, low-amplitude ultrasound energy used in medical
imaging, HIFU results in both thermal and mechanical
effects that cause tissue damage. It has been used to break
down blood clots and kidney and gallbladder stones, ablate
tumors, and cause lipolysis. Dr. Ludomirsky’s team has been
investigating the use of HIFU to create targeted lesions in
cardiac tissue. Using ultrasound imaging guidance, the
HIFU system generates a burst of energy at a specific
amplitude, frequency, and duration, resulting in tissue
damage at a specific depth and tissue volume. Their in vitro
experiments have shown that precise defects could be
created in the atrial septum, ventricular septum, pulmonary
valve, pericardium, and other samples of cardiac tissue. In
the future, Dr. Ludomirsky aims to further refine the
instrumentation and technique of HIFU, raising the possi-
bility of clinical applications such as performing atrial
septectomy or opening a stenotic valve noninvasively.
Dr. Azaria Rein from the Hadassa University in Jerusa-
lem presented new techniques for post-processing, display,
and analysis of tissue Doppler imaging (TDI). Dr. Rein’s
group measured LV and right ventricular myocardial veloc-
ities and strain rate in 98 healthy fetuses whose gestational
age ranged from 16 to 40 weeks. The group from Jerusalem
found that while myocardial velocities exhibited a close
positive linear association with gestational age, there was no
significant correlation between strain rate and gestational
age, indicating that the strain rate is independent of matu-
rational changes in cardiac function. Dr. Rein also presented
a new technique for computerized automatic tracking of
ventricular myocardium. His group’s work appears promis-
ing for the assessment of regional myocardial function and
arrhythmias, both prenatally and postnatally.
Echocardiographically guided catheter procedures. An-
other area that generated intense interest was echocardio-
graphically guided transcatheter intervention in the fetus.
Dr. Wayne Tworetzky from the Children’s Hospital in
Boston reviewed his center’s experience with 20 fetal cardiac
interventions, including 13 balloon aortic valvuloplasties for
critical aortic stenosis, 5 atrial septostomies for an intact or
restrictive atrial septum, and 2 balloon pulmonary valvulo-
plasties for pulmonary atresia with an intact ventricular
septum. Procedures were performed after institutional re-
view board approval and informed consent, with maternal
general anesthesia, uterine relaxation, and fetal anesthesia.
Initial procedures were performed with the needle advanced
through the maternal abdomen and uterine wall and then
through the fetal chest wall and cardiac chambers. Later in
the experience of Dr. Tworetzky and his colleagues, several
procedures incorporated a laparotomy and uterine exposure
to facilitate optimal fetal positioning and better orientation
of the needle relative to the target cardiac structure. The
investigators achieved technical success in 13 of 20 aortic
valve dilations, 5 of 5 atrial septostomies, and 0 of 2
pulmonary atresia cases.
Echocardiography as an investigational tool. Dr. Steven
Colan from the Children’s Hospital in Boston and Dr.
Colin Phoon from the New York University highlighted the
use of echocardiography as a research tool in clinical trials
and laboratory animals. Dr. Colan discussed challenges
faced by investigators who design and implement multi-
center clinical trials in which outcome variables are mea-
sured by echocardiography. Dr. Phoon presented his work
on assessment of cardiovascular physiology in mice embryos.
Using Doppler techniques, Dr. Phoon and his group non-
invasively measured blood flow as early as the straight heart
tube stage. This remarkable technologic achievement opens
the door for further research on the interactions between
genetics, cardiac morphogenesis, and embryonic cardiovas-
cular physiology.
MRI. Dr. Andrew Powell from the Children’s Hospital in
Boston and Dr. Mark Fogel from the Children’s Hospital in
Philadelphia discussed the increasing role of MRI as a
complementary modality to echocardiography in the non-
invasive evaluation of CHD. Dr. Powell presented data on
the use of velocity-encoded cine MRI to quantify the shunt
ratio in patients with an atrial septal defect. Compared with
catheterization-based oximetry, the mean difference (bias)
between the two techniques was 2.3%, with upper and lower
limits of agreement of 0.54 and 0.42, respectively. Dr.
Powell also discussed the use of MRI to evaluate myocardial
perfusion and viability in patients with CHD. In his
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presentation, Dr. Fogel concentrated on the complementary
role of MRI in the evaluation of right ventricular function
and emphasized its strengths compared with two-
dimensional echocardiography, including its independence
of acoustic windows and geometric assumptions.
Considerable interest focused on the use of TDI for
evaluation of ventricular function (9–12). Pauliks et al. (11)
found that isovolumic acceleration is more reflective of
myocardial contractility than are the more traditional TDI
indexes of peak systolic (S-wave) myocardial velocity. Taken
together with other abstracts and recent publications on
TDI in patients with CHD, the emerging impression
suggests that this technique can detect global and regional
ventricular dysfunction. However, further research is re-
quired to determine its sensitivity, specificity, reproducibil-
ity, and prognostic value in the pediatric age group. Hej-
madi et al. (13) presented the use of three-dimensional
echocardiography to measure LV and right ventricular mass
in 30 fetuses ranging in gestational age from 12 to 31 weeks.
Right and left ventricular mass correlated with each other
and with gestational age. In another abstract presentation
on fetal echocardiography, Spurney et al. (14) presented a
study on the assessment of fetal mouse cardiovascular
function. The primary goal of their study was to establish a
Web-based data base of normal values and digital images.
Using a 15-MHz linear phased-array transducer, they lon-
gitudinally studied over 1,000 C57BL/6J mouse fetuses
from 12.5 to 18.5 days after conception. Their database
includes fetal crown to rump length, heart rate, shortening
fraction, myocardial performance index, and Doppler in-
dexes of inflow and outflow velocities. The research com-
munity that studies genetically modified mice models of
cardiovascular anomalies can use this Web-based normative
database.
ASE 2004
Next year’s meeting will be held in San Diego, California,
on June 27 to 30. In addition to the program elements
outlined thus far, ASE 2004 will feature a “Meeting Within
a Meeting,” a multidisciplinary approach to patients with
atrial fibrillation.
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